The most recent listing of current clinical trials for gastrointestinal cancers — including colon, rectal, anal and gastroesophageal — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Gastrointestinal
(Includes Colon, Rectal, Anal
and Gastroesophageal)
| Protocol ID |
|
Title |
|
| N0147 |
|
A Randomized Phase III Trial of Irinotecan (CPT-11) and/or Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
Keywords: after curative resection for patients with Stage III colon cancer |
|
| E5202 |
|
A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin, and Bevcizumab in Patients with State II Colon Cancer at HIgh Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
Keywords: Stage II Colon Cancer at High Risk for Recurrence |
|
Memorial Sloan Kettering
(also in GI) |
|
A Random Assignment Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) versus Parent DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma
Keywords: Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma |
|
| In-House-geriatric |
|
Use of the Comprehensive Geriatric Assessment in Older Colorectal Cancer Patients to Identify Vulnerability and Guide Treatment Choices
Keywords: geriatric colorectal cancer patients |
|
| CALGB 80101 |
|
Phase III Intergroup of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
Keywords: adjuvant chemoradiation after resection of gastric or gastroesophageal adenocarcimoma |
|
| ACOSOG Z9001 |
|
A Phase III Randomized Double-Blind Study of Adjuvant STI571 (Gleevec™) Versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor (GIST)
Keywords: after resection of primary gastrointestinal stromal tumor |
|
| U of C 13780A |
|
A Phase II Study of BAY 43-9006 for Patients with Imatinib- Resistant Malignant Gastrointestinal Stromal Tumor
Keywords: patients with Imatinib-resistant malignant gastrointestinal stromal tumor |
|
| National/Multicenter |
|
TheraSphere for the Treatment of Liver Metastases: An Open Label Trial of TheraSphere in Patients with liver Metastases from Primary Colorectal Cancer, Neuroendocrine Cancer or Non-Colorectal/Non-Neuroendocrine Cancer
Keywords: liver Metastases from Primary Colorectal Cancer, Neuroendocrine Cancer or Non-Colorectal/Non-Neuroendocrine Cancer |